“Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading ->
Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen. Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading ->
The latest episode of the Global Health Matters podcast, hosted by Dr Garry Aslanyan, delves into the extraordinary careers of two global health leaders and the crucial role that capacity development has played in their journeys. This episode, produced to celebrate the 50th anniversary of TDR, the Special Programme for Research and Training in Tropical […] Continue reading ->
Around 55 million people worldwide live with dementia, and an estimated 60% to 80% of those individuals suffer from Alzheimer’s Disease (AD), according to the World Health Organization (WHO). That number is expected to increase to around 139 million within 25 years. Projections from the National Center for Health Workforce Analysis indicate that by 2025, […] Continue reading ->
Cabo Verde, a group of 10 islands in the Central Atlantic Ocean, was declared malaria-free in January. This milestone makes it one of the 43 countries and territories globally recognised with this certification by the World Health Organization (WHO). Cabo Verde is only the third country in the WHO African region to be certified malaria-free […] Continue reading ->
GENEVA – Partnerships between industry, multilateral organizations, and other stakeholders are essential to overcoming challenges and improving access to innovations. This was the key message at an International Federation of Pharmaceutical Manufacturers (IFPMA) event on Tuesday evening, held on the sidelines of the World Health Assembly in Geneva. The gathering brought together representatives from the […] Continue reading ->
As the world grapples with a migrant and refugee crisis of unprecedented scale, with 281m international migrants and 3.5m refugees globally, according to UN agencies, experts are turning to technology, particularly artificial intelligence, in search of solutions. The potential for AI and technology to foster a more equitable and sustainable world has been recognised by […] Continue reading ->
GENEVA — Six of the ten leading risk factors for premature deaths and years of healthy life lost due to disability are within an individual’s control, according to new data from the Global Burden of Disease Study 2021. The study, the most comprehensive effort to quantify health loss worldwide to date, aims to identify and […] Continue reading ->
The rising cost of healthcare is one of the most significant burdens on countries, especially low- and middle-income countries. Research has shown that self-care can be critical in reducing unnecessary expenses for healthcare systems. Global self-care activities generate substantial monetary and healthcare workforce savings, totalling at least approximately $119 billion per year, according to a […] Continue reading ->
Three years ago, Dr. Garry Aslanyan searched for a global health podcast he wanted to listen to. When he could not find one, he decided to start his own. “I like podcasts as a tool in other areas, such as politics and current affairs,” Aslanyan told Health Policy Watch. “Podcasts allow for the most open […] Continue reading ->